Table 3.
Category | Subgroups | Number of patients alive | Number of deceased patients (FU 31-12-2016) | Kappa statistic | Spearman’s correlation coefficient and p-value |
---|---|---|---|---|---|
Age | <40 years | 177 | 11 | NDa |
Rho= -0.7 P-value= 0.23 |
40-49 | 525 | 37 | 0.64 | ||
50-59 | 736 | 42 | 0.83 | ||
60-69 | 649 | 60 | 0.73 | ||
70-79 | 334 | 89 | 0.54 | ||
≥80 | 87 | 115 | 0.50 | ||
Year of diagnosis | 2009 | 393 | 96 | 0.77 |
Rho= -0.26 P-value= 0.67 |
2010 | 379 | 69 | 0.59 | ||
2011 | 398 | 70 | 0.71 | ||
2012 | 429 | 54 | 0.67 | ||
2013 | 472 | 28 | 0.78 | ||
2014 | 437 | 37 | 0.54 | ||
Stage at diagnosis | Stage 0 | 46 | 1 | NDa |
Rho= -0.8 P-value= 0.33 |
Stage I | 1019 | 44 | 0.76 | ||
Stage II | 1053 | 121 | 0.69 | ||
Stage III | 288 | 69 | 0.75 | ||
Stage IV | 56 | 102 | 0.35 | ||
Stage unknownb | 46 | 17 | 0.43 | ||
Grade of tumor | Grade 1 | 301 | 18 | NDa | NDc |
Grade 2 | 1223 | 155 | 0.58 | ||
Grade 3 | 960 | 166 | 0.81 | ||
Grade unknownb | 24 | 15 | 0.86 | ||
Multiple tumors | Yes | 94 | 35 | 0.66 | NDc |
No | 2414 | 319 | 0.69 |
aNot defined due to events within subgroup being too small
b subgroups with unknown stage or grade were not included in Spearman analyses
cnot defined due to subgroup without ranked variables